Prevalencia de HTA y frecuencia de pacientes controlados en una muestra hospitalaria
DOI :
https://doi.org/10.22529/me.2024.9(4)05Mots-clés :
hipertensión arterial, enfermedad cardiovascular, infarto, ACV, secuelas, pandemiaRésumé
La hipertensión sigue siendo un importante desafío de la salud pública en todo el mundo porque aumenta el riesgo de enfermedad cardiovascular. Se ha demostrado que el manejo eficaz de la presión arterial reduce la incidencia de Acv, ataque cardiaco e Insuficiencia cardiaca. La prevalencia actual en nuestro país de Hta es del 36,3%. En el estudio Renata 2 cuatro de cada diez pacientes Hta, desconocen su condición. Esta observación no es ajena a lo que sucede globalmente. En el estudio Pure, solo se logra controlar al 13% de los hipertensos. El 30% tuvo tensión arterial óptima y el otro 30% se encontraba en prehipertensión Del 40%de los pacientes con Hta, el 40% recibían tratamiento, pero solo el 13% tenían controlada su enfermedad. Este trabajo de investigación que se realiza en el Servicio de Cardiología del Hospital Nacional de Clínicas de la ciudad de Córdoba, tiene como objetivos evaluar la prevalencia de Hta y frecuencia de pacientes controlados que concurren a consultorio externo. de Cardiología entre el mes de abril de 2021-febrero 2022. Los datos serán obtenidos de una muestra al azar mediante la utilización de historias clínicas entre el mes de abril 2021-febrero 2022.Un año de Pandemia. La hipótesis el comprobar el insuficiente control de la hipertensión arterial más allá de lo encontrados en los resultados de los estudios antes mencionados, en nuestra población de la Ciudad de Córdoba, y en un año totalmente diferente, un año de Pandemia. En donde el acceso a la salud se encuentra limitada por el COVID 19.Téléchargements
Références
UN, United Nations. Report of the DirectorGeneral of the World Health Organization on the Prevention and control of non-communicable diseases. Document A/R68/650. 2013.
Dutta U, Nagi B, Garg PK, Sinha SK, Singh K, Tandon RK. Patients with gallstones develop gallbladder cancer at an earlier age. Eur J Cancer Prev. 2005; 14:381-85 https://doi.org/10.1097/00008469-200508000-00011
Gajalakshmi CK, Shanta V, Swaminathan R, Sankaranarayanan R, Black RJ. A populationbased survival study on female breast cancer in Madras, India. Br J Cancer. 1997; 75:771-75. https://doi.org/10.1038/bjc.1997.137
Mendis, S. Global status report on noncommunicable diseases 2014. 2014. Disponible en: http://www.who.int/nmh/publications/ncd- atusreport-2014/en/. Consultado: 29 de Julio de 2021.
Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, et al. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials 2014; 11(5):532-46. https://doi.org/10.1177/1740774514537404
Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: An overview of published reviews. Stroke 2004; 35(4):1024. https://doi.org/10.1161/01.STR.0000126208.14181.DD
Zanchetti A, Thomopoulos C, Parati G. Randomized controlled trials of blood pressure lowering in hypertension: A critical reappraisal. Circ Res 2015; 116(6):1058-73. https://doi.org/10.1161/CIRCRESAHA.116.303641
Fryar CD, Ostchega Y, Hales CM, Zhang G, Kruszon-Moran D. Hypertension Prevalence and Control Among Adults: United States, 2015- 2016. NCHS Data Brief 2017; (289):1-8.
Yusuf S, Hawken S, Ounpuu S, et al; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364(9438):937-52. https://doi.org/10.1016/S0140-6736(04)17018-9
Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. PURE Study Investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013; 310:959-968. https://doi.org/10.1001/jama.2013.184182
NCD Risk Factor Collaboration. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet 2017; 389:37-55.
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217-223. https://doi.org/10.1016/S0140-6736(05)17741-1
Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, metaanalyses, and meta-regression analyses of randomized trials. J Hypertens 2014; 32:2285- 95. https://doi.org/10.1097/HJH.0000000000000378
Brunstrom M, Carlberg B. Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis. JAMA Intern Med 2018; 178:28-36. https://doi.org/10.1001/jamainternmed.2017.6015
Sundstrom J, Arima H, Jackson R, Turnbull F, Rahimi K, Chalmers J, et al., Blood PressureLowering Treatment Trialists' Collaboration. Effects of blood pressure reduction in mild hypertension: a systematic review and metaanalysis. Ann Intern Med 2015; 162:184-191. https://doi.org/10.7326/M14-0773
Lonn EM, Bosch J, Lopez-Jaramillo P, Zhu J, Liu L, Pais P, et al., HOPE-3 Investigators. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med 2016; 374:2009-2020. https://doi.org/10.1056/NEJMoa1600175
Ordunez P, Martinez R, Niebylski ML, Campbell NR. Hypertension prevention and control in Latin America and the Caribbean.J Clin Hypertens. 2015; 17:499-502. https://doi.org/10.1111/jch.12518
PAHO, Pan American Health Organization. Deaths due to non-communicable diseases in countries of the Americas, regional mortality database2014. http://www.paho.org/hq/index.php?option=com content&view=article&id=5967%3A2011-noncommunicableiseases&catid=2390%3Aregional-healthobservatory-themes&Itemid=2391&lang=en
Chor D, Pinho Ribeiro AL, Sá Carvalho M, Duncan BB, Andrade Lotufo P, Araújo Nobre A, et al. Prevalence, awareness, treatment and influence of socioeconomic variables on control of high blood pressure: results of the ELSABrasil Study. PLOS ONE 2015; 10: e0127382. https://doi.org/10.1371/journal.pone.0127382
Kuri-Morales P, Emberson J, Alegre-Diaz J, Tapia-Conyer R, Collins R, Peto R, et al. The prevalence of chronic diseases andmajor disease risk factors at different ages among 150 000 men and women living in Mexico City: crosssectional analyses of a prospective study. BMC Public Health. 2009; 9:9. https://doi.org/10.1186/1471-2458-9-9
Rubinstein AL, Irazola VE, Calandrelli M, Chen CS, Gutierrez L,Lanas F, et al. Prevalence, awareness, treatment, and controlof hypertension in the southern cone of Latin America. Am J Hypertens. 2016 Dec 1;29(12):1343-1352. https://doi.org/10.1093/ajh/hpw092
WHO, World Health Organization. Global status report on noncommunicable diseases 2010. Geneva, World Health Organization, 2011.
WHO, World Health Organization. Global Health Observatory Data Repository. Geneva, World Health Organization, 2008.
Delucchi AM, Majul CR, Vicario A, Cerezo GH, Fábreguez G; Invertigadores 2° Registro Nacional de Hipertensión Arterial (RENATA 2). Registro Nacional de Hipertensión Arterial. Características epidemiológicas de la hipertensión arterial en la Argentina. Estudio RENATA 2. Rev Argent Cardiol 2017; 85:354- 360.
WHO. A global brief on Hypertension. Silent killer, global public health crisis. 2013. http://apps.who.int/iris/bitstream/10665/79059
Delucchi AM, Majul CR, Vicario A, Cerezo GH, Fábreguez G; Invertigadores 2° Registro Nacional de Hipertensión Arterial (RENATA 2). Registro Nacional de Hipertensión Arterial. Características epidemiológicas de la hipertensión arterial en la Argentina. Estudio RENATA 2. Rev Argent Cardiol 2017; 85:354- 360.
Chow CK, Teo KK, Rangarajan S, Gupta R, Yusuf S; and Study investigators PURE (Prospective Urban Rural Epidemiology). Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013; 310(9):959-68. https://doi.org/10.1001/jama.2013.184182
Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S. Trends in hypertension prevalence, awareness, treatment, and control in older US adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc. 2007;55(7):1056-1065. https://doi.org/10.1111/j.1532-5415.2007.01215.x
Gupta A, Arshad S, Poulter N. Compliance, safety and effective¬ness of fixed dose combinations of antihypertensive agents: a metaanalysis. Hypertension 2010; 55:399-407. https://doi.org/10.1161/HYPERTENSIONAHA.109.139816
Burke T, Sturkenboom M, Lu S, Wentworth C, Lin Y, Rhoads G. Discontinuation of antihypertensive drugs among newly diag¬nosed hypertensive patients in UK general practice. J Hypertens 2006; 24:1193-200. https://doi.org/10.1097/01.hjh.0000226211.95936.f5
Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med 2012; 125:882-87. https://doi.org/10.1016/j.amjmed.2011.12.013
Ingaramo R, Vita N, Bendersky M, Arnolt M, Bellido C, Piskorz D y cols. Estudio Nacional Sobre Adherencia al Tratamiento (ENSAT). Rev Fed Arg Cardiol 2005; 34:104-11.
Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F; Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013 Jul;31(7):1281-357.PMID: 23817082. https://doi.org/10.1097/01.hjh.0000431740.32696.cc
Kinsara AJ. Ambulatory blood pressure monitoring in daily practice. Indian Heart J. 2017 Nov-Dec;69(6):788-789. Epub 2017 Oct 5. PMID: 29174260; PMCID: PMC5717310. https://doi.org/10.1016/j.ihj.2017.09.223
Guzik A, Bushnell C. Stroke Epidemiology and Risk Factor Management. Continuum (Minneap Minn). 2017 Feb;23(1, Cerebrovascular Disease):15-39. PMID: 28157742. https://doi.org/10.1212/CON.0000000000000416
Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of PopulationBased Studies From 90 Countries. Circulation. 2016 Aug 9;134(6):441-50. PMID: 27502908; PMCID: PMC4979614. https://doi.org/10.1161/CIRCULATIONAHA.115.018912
Banegas JR, Navarro-Vidal B, Ruilope LM, de la Cruz JJ, López-García E, RodríguezArtalejo F, Graciani A. Trends in hypertension control among the older population of Spain from 2000 to 2001 to 2008 to 2010: role of frequency and intensity of drug treatment. Circ Cardiovasc Qual Outcomes. 2015 Jan;8(1): 67- 76. PMID: 25604557. https://doi.org/10.1161/CIRCOUTCOMES.114.001191
Llisterri JL, Rodriguez-Roca GC, Escobar C, Alonso-Moreno FJ, Prieto MA, Barrios V, González-Alsina D, Divisón JA, Pallarés V, Beato P; Working Group of Arterial Hypertension of the Spanish Society of Primary Care Physicians Group HTASEMERGEN; PRESCAP 2010 investigators. Treatment and blood pressure control in Spain during 2002- 2010. J Hypertens. 2012 Dec;30(12):2425-31. PMID: 22990354. https://doi.org/10.1097/HJH.0b013e3283592583
Wilber JA, Barrow JG. Hypertension - a community problem. Am J Med1972; 52:653-63. https://doi.org/10.1016/0002-9343(72)90055-1
